论文部分内容阅读
目的分析生化检验中化学发光免疫测定技术的使用方法以及效果,为临床提供依据。方法选取2013年1月到2014年1月甲状腺肿瘤患者资料108例实施回顾性分析,将108例患者随机分为两组,观察组54例,对照组54例,观察组患者通过化学发光免疫方法实施检测,对照组患者通过放射免疫分析方法实施检测,比较观察组和对照组患者测定特异性、敏感度以及符合率,将结果进行统计学分析。结果观察组患者检测特异性、期敏感度以及符合率全部高于对照组患者,两组比较差异具有统计学意义(P<0.05)。结论生化检验中实施化学发光免疫测定技术的效果显著,针对明确病情患者的意义十分重要,应该在临床中大力推广使用。
Objective To analyze the use and effect of chemiluminescence immunoassay in biochemical tests and provide the basis for clinical application. Methods A retrospective analysis was performed on 108 patients with thyroid tumors from January 2013 to January 2014. 108 patients were randomly divided into two groups: 54 cases in the observation group and 54 cases in the control group. The patients in the observation group were treated by chemiluminescence immunoassay The patients in the control group were tested by radioimmunoassay. The specificity, sensitivity and coincidence rate of the observation group and the control group were compared, and the results were statistically analyzed. Results The specificity, the sensitivity and the coincidence rate of observation group were all higher than those of the control group. The differences between the two groups were statistically significant (P <0.05). Conclusion The results of chemiluminescence immunoassay in biochemical tests are significant. It is very important to clarify the significance of patients with disease and should be promoted in clinical practice.